Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.
Arbyn M, Cuschieri K, Bonde J, Schuurman R, Cocuzza C, Broeck DV, Zhao FH, Rezhake R, Gultekin M, de Sanjosé S, Canfell K, Hawkes D, Saville M, Hillemanns P, Dillner J, Berkhof J, Prétet JL, Gheit T, Clifford G, Basu P, Almonte M, Wentzensen N, Poljak M. Arbyn M, et al. Among authors: saville m. J Med Virol. 2024 Sep;96(9):e29881. doi: 10.1002/jmv.29881. J Med Virol. 2024. PMID: 39221498 Review.
Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.
Tsimberidou AM, Grothey A, Sigal D, Lenz HJ, Hochster HS, Chao Y, Bai LY, Yen CL, Xu D, Saville MW. Tsimberidou AM, et al. Among authors: saville mw. Cancer Chemother Pharmacol. 2024 Sep 23. doi: 10.1007/s00280-024-04714-z. Online ahead of print. Cancer Chemother Pharmacol. 2024. PMID: 39311947
Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study.
Velentzis LS, Egger S, Waller J, Jennett CJ, Brotherton JML, Smith MA, Bateson D, Rogers C, Pagotto A, Skinner R, Taylor N, Edge R, Saville M, Canfell K. Velentzis LS, et al. Among authors: saville m. Prev Med Rep. 2024 Aug 5;45:102849. doi: 10.1016/j.pmedr.2024.102849. eCollection 2024 Sep. Prev Med Rep. 2024. PMID: 39220611 Free PMC article.
From commitments to action: the first global cervical cancer elimination forum.
Almonte M, Ilbawi AM, Maza M, Saville M, Murillo R, Forestier M, Bloem P, Luciani S, Mikkelsen B. Almonte M, et al. Among authors: saville m. Lancet Reg Health Am. 2024 Jun 12;36:100812. doi: 10.1016/j.lana.2024.100812. eCollection 2024 Aug. Lancet Reg Health Am. 2024. PMID: 38974379 Free PMC article. No abstract available.
DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging.
Molano M, Machalek DA, Phillips S, Tan G, Garland SM, Hawkes D, Balgovind P, Haqshenas R, Badman SG, Bolnga J, Gabuzzi J, Kombati Z, Munnull GM, Brotherton JM, Saville M, Kaldor JM, Toliman PJ, Vallely AJ, Murray GL. Molano M, et al. Among authors: saville m. Tumour Virus Res. 2024 Jul 1;18:200288. doi: 10.1016/j.tvr.2024.200288. Online ahead of print. Tumour Virus Res. 2024. PMID: 38960143 Free PMC article.
Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea.
Molano M, Machalek DA, Tan G, Garland S, Balgovind P, Haqshenas G, Munnull G, Phillips S, Badman SG, Bolnga J, Cornall AM, Gabuzzi J, Kombati Z, Brotherton J, Saville M, Hawkes D, Kaldor J, Toliman PJ, Vallely AJ, Murray GL. Molano M, et al. Among authors: saville m. BMJ Open. 2024 Jun 19;14(6):e081282. doi: 10.1136/bmjopen-2023-081282. BMJ Open. 2024. PMID: 38904134 Free PMC article.
A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
Lawton B, MacDonald EJ, Storey F, Stanton JA, Adcock A, Gibson M, Parag V, Sparkes NK, Kaimoana B, King F, Terry M, Watson H, Bennett M, Lambert CS, Geller S, Paasi I, Hibma M, Sykes P, Hawkes D, Saville M. Lawton B, et al. Among authors: saville m. JMIR Res Protoc. 2023 Sep 14;12:e51643. doi: 10.2196/51643. JMIR Res Protoc. 2023. PMID: 37707939 Free PMC article.
225 results